Financial & Business

Movemedical, Resurgens Technology Partner on Medtech Supply Chain Innovation

Movemedical's enterprise software platform seeks to set the gold standard for medical device inventory management.

By: Michael Barbella

Managing Editor

Movemedical has forged a strategic investment partnership with Resurgens Technology Partners that will provide enterprise software platform developer with capital to help it unite the medical device supply chain and drive continued innovation within the medtech industry.

“As we expand, our commitment to innovation and uniting the fragmented medical device supply chain remains central,” Movemedical Founder/CEO Bo Molocznik said. “We believe we can rapidly advance our platform, ensuring we stay ahead of the curve while continuing to deliver value to our growing customer partners.”

“We are currently disrupting this industry with our technology, and this investment allows us to scale even further,” Movemedical President Josh Weeks added. “Our success is driven by the people and industry experts who are deeply committed to pushing boundaries and solving the most complex supply chain challenges. With this new partnership, we aspire to continue leading the way for our customers and the industry.”

Movemedical will use the investment to continue building the team, adding depth and capabilities across all functions of the business to accelerate the expansion of the firm’s global footprint, while continuing to provide customers with real-time visibility, optimized inventory control, and seamless supply chain collaboration.

“The inefficiency and fragmented nature of medical device supply chains drive cost and complexity through our healthcare system,” Resurgens Technology Partners Principal Danny Carpenter stated. “We’re excited about the opportunity to partner with the team at Movemedical, their customers and partners to reshape these critical business processes and improve the cost and quality of global healthcare delivery.”

This investment marks the tenth platform investment from Resurgens’ second fund, a $500 million vehicle that closed in 2022.

Vedder Price advised Movemedical and DLA Piper advised Resurgens on the transaction.

“We set out to help grow companies that we view as leaders in their markets,” Resurgens Technology Partners Managing Director Adi Filipovic commented, “and we believe Movemedical is uniquely positioned to lead an industry-wide transformation of the way medical device supply chains are managed.”

Movemedical delivers comprehensive visibility and control over medical device manufacturing, storage, and distribution. With the client support, Movemedical seeks to optimize inventory management, reduce waste, and improve supply chain operational efficiency, empowering the field, healthcare professionals, and providers to focus on patient care.

Movemedical’s enterprise software platform seeks to set the gold standard for medical device inventory management by transforming the digital landscape through innovation, efficiency, and scalability. The company’s seamless integration with enterprise systems and its ability to handle both small/mid-sized companies without custom configuration, while accommodating the complexities of large enterprises, positions it as a flexible and powerful solution. Movemedical believes its platform drives industry standards, pushing companies toward more efficient operations through transparency, data-driven decision-making, and advanced compliance features.

Resurgens Technology Partners is an experienced private equity firm that partners with growth-oriented software companies. Specializing in strategic investments and hands-on operational support, Resurgens works closely with leadership teams to accelerate business growth, enhance value creation, and scale market-leading companies. Resurgens’ expertise spans across various industries, making the firm an ideal partner for driving long-term success in tech-enabled businesses.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters